New 1-indanone thiosemicarbazone derivatives active against BVDV

Eur J Med Chem. 2008 Aug;43(8):1767-73. doi: 10.1016/j.ejmech.2007.10.023. Epub 2007 Oct 25.

Abstract

Identification of new therapeutic agents for the treatment of viral diseases represents an area of active investigation. In an effort to develop new antiviral compounds, a series of 1-indanone thiosemicarbazone derivatives were synthesized. These derivatives were structurally characterized using several spectroscopic techniques and evaluated against bovine viral diarrhoea virus as a surrogate model for hepatitis C virus. Thiosemicarbazone 2m showed potent anti-bovine viral diarrhoea virus activity with a higher selectivity index (SI=80.29) than that of ribavirin (SI=11.64). This result determines the potentiality of these thiosemicarbazones as antiviral agents for the treatment of infections caused by other highly related members of Flaviviridae family, as hepatitis C virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antiviral Agents / chemical synthesis*
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Cattle
  • Cell Line
  • Diarrhea Viruses, Bovine Viral / drug effects*
  • Indans / chemical synthesis
  • Indans / chemistry*
  • Indans / pharmacology
  • Molecular Structure
  • Structure-Activity Relationship
  • Thiosemicarbazones / chemical synthesis*
  • Thiosemicarbazones / chemistry
  • Thiosemicarbazones / pharmacology*

Substances

  • 5,6-dimethoxy-1-indanone thiosemicarbazone
  • Antiviral Agents
  • Indans
  • Thiosemicarbazones
  • indacrinone